Takeda, Frazier Healthcare to form HilleVax for HIL-214 norovirus vaccine
Japanese pharmaceutical firm Takeda has teamed up with US-based venture capital firm Frazier Healthcare Partners to create a new biopharmaceutical company HilleVax. HilleVax is designed to develop and